![]() |
Dyslipidemia |
Free Subscription
1 Am Fam Physician |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Dyslipidemia is free of charge.
Health Maintenance in Postmenopausal Women.
Am Fam Physician. 2025;111:407-418.
PubMed
Abstract available
Impact of a personalized, strike early and strong approach on non-HDL-cholesterol
levels and outcome in patients with acute myocardial infarction.
Int J Cardiol. 2025 Apr 29:133327. doi: 10.1016/j.ijcard.2025.133327.
PubMed
Abstract available
Approach to Lipid Management in the Patient with Diabetes.
J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210.
PubMed
Abstract available
Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish
Observational Multicenter Study.
J Clin Endocrinol Metab. 2025;110:e1811-e1820.
PubMed
Abstract available
Associations Between Visceral and Liver Fat and Cardiac Structure and Function: A
UK Biobank Study.
J Clin Endocrinol Metab. 2025;110:e1856-e1865.
PubMed
Abstract available
Topiramate added to metformin for obesity control in women with polycystic ovary
syndrome: a randomized clinical trial.
J Clin Endocrinol Metab. 2024 Sep 14:dgae637. doi: 10.1210.
PubMed
Abstract available
Predictors of cardiovascular disease in individuals with dysbetalipoproteinemia:
a prospective study in the UK Biobank.
J Clin Endocrinol Metab. 2024 Sep 7:dgae618. doi: 10.1210.
PubMed
Abstract available
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction
(TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet. 2025;405:1757-1768.
PubMed
Abstract available
Association of the newly proposed dietary index for gut microbiota and
hyperlipidemia: From the 2007-2020 NHANES study.
PLoS One. 2025;20:e0323887.
PubMed
Abstract available
Semaglutide 2.4 mg long-term clinical outcomes in patients with obesity or
overweight: a real-world retrospective cohort study in the United States (SCOPE
12 months).
Postgrad Med. 2025;137.
PubMed
Abstract available
Thank you for your interest in scientific medicine.